DE602007013524D1 - Erkennung und vorhersage von frühgeburten - Google Patents

Erkennung und vorhersage von frühgeburten

Info

Publication number
DE602007013524D1
DE602007013524D1 DE602007013524T DE602007013524T DE602007013524D1 DE 602007013524 D1 DE602007013524 D1 DE 602007013524D1 DE 602007013524 T DE602007013524 T DE 602007013524T DE 602007013524 T DE602007013524 T DE 602007013524T DE 602007013524 D1 DE602007013524 D1 DE 602007013524D1
Authority
DE
Germany
Prior art keywords
prediction
detection
technology described
births
early
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007013524T
Other languages
German (de)
English (en)
Inventor
Lucilla Poston
Andrew Shennan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revvity Health Sciences Inc
Original Assignee
PerkinElmer LAS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PerkinElmer LAS Inc filed Critical PerkinElmer LAS Inc
Publication of DE602007013524D1 publication Critical patent/DE602007013524D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Mold Materials And Core Materials (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Holo Graphy (AREA)
DE602007013524T 2006-01-17 2007-01-17 Erkennung und vorhersage von frühgeburten Active DE602007013524D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia
PCT/GB2007/000123 WO2007083099A1 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia

Publications (1)

Publication Number Publication Date
DE602007013524D1 true DE602007013524D1 (de) 2011-05-12

Family

ID=35998177

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007013524T Active DE602007013524D1 (de) 2006-01-17 2007-01-17 Erkennung und vorhersage von frühgeburten

Country Status (10)

Country Link
US (1) US7638287B2 (enExample)
EP (1) EP1974220B1 (enExample)
JP (1) JP2009524014A (enExample)
AT (1) ATE504002T1 (enExample)
AU (1) AU2007206756B2 (enExample)
CA (1) CA2602681C (enExample)
DE (1) DE602007013524D1 (enExample)
ES (1) ES2364314T3 (enExample)
GB (1) GB0600916D0 (enExample)
WO (1) WO2007083099A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008098734A1 (en) 2007-02-12 2008-08-21 Stefan Hansson Diagnosis and treatment of preeclampsia
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
US8647832B2 (en) 2008-01-25 2014-02-11 Perkinelmer Health Sciences, Inc. Methods for determining the risk of prenatal complications
CN102224422A (zh) * 2008-11-20 2011-10-19 珀金埃尔默健康科学公司 使用pigf-2和pigf-3标志物确定先兆子痫风险的方法
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
AU2011231982B2 (en) * 2010-03-24 2014-02-20 Preelumina Diagnostics Ab HbF and A1M as early stage markers for preeclampsia
WO2013087887A2 (en) * 2011-12-15 2013-06-20 Pronota N.V. Biomarkers and parameters for hypertensive disorders of pregnancy
ES2718905T3 (es) * 2012-04-24 2019-07-05 Siemens Healthcare Diagnostics Inc Métodos de examen de preeclampsia
WO2014124396A1 (en) * 2013-02-08 2014-08-14 University Of Iowa Research Foundation Therapeutic strategies for the treatment of preeclampsia
US10119978B2 (en) * 2013-03-15 2018-11-06 Wallac Oy System and method for determining risk of diabetes based on biochemical marker analysis
EP3189336B1 (en) 2014-09-02 2018-11-07 Wallac OY Method for determining risk of pre-eclampsia
FR3037657B1 (fr) * 2015-06-22 2017-06-23 Univ Rouen Centre Hospitalier Methode de diagnostic des troubles causes par l'alcoolisation foetale
US20200395127A1 (en) * 2017-11-17 2020-12-17 University Of Washington Connected system for information-enhanced test results
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS
GB2620035A (en) * 2021-02-10 2023-12-27 Mirvie Inc Methods and systems for conducting pregnancy-related clinical trials
FR3157091A1 (fr) * 2023-12-26 2025-06-27 Universite De Montpellier Prédiction du comportement biomécanique de la paroi artérielle à travers l’analyse temporelle du signal oscillométrique au cours de la mesure de pression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5331298A (en) 1996-12-23 1998-07-17 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
GB0026823D0 (en) 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
US7344892B2 (en) * 2003-09-23 2008-03-18 Beth Israel Deaconess Medical Center, Inc. Screening for gestational disorders
CA2485722A1 (en) * 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor

Also Published As

Publication number Publication date
ES2364314T8 (es) 2011-09-22
CA2602681A1 (en) 2007-07-26
CA2602681C (en) 2017-03-14
AU2007206756A1 (en) 2007-07-26
US20070178530A1 (en) 2007-08-02
GB0600916D0 (en) 2006-02-22
AU2007206756B2 (en) 2011-06-16
EP1974220A1 (en) 2008-10-01
JP2009524014A (ja) 2009-06-25
EP1974220B1 (en) 2011-03-30
WO2007083099A1 (en) 2007-07-26
US7638287B2 (en) 2009-12-29
ATE504002T1 (de) 2011-04-15
HK1119244A1 (en) 2009-02-27
ES2364314T3 (es) 2011-08-31

Similar Documents

Publication Publication Date Title
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
WO2009058902A3 (en) Methods and devices for analyte detection
MX350533B (es) Biomarcadores de cancer pancreatico y usos de los mismos.
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2020004617A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
MX2009000914A (es) Medios y metodos para evaluar el riesgo de intervenciones cardiacas basadas en el factor 15 de diferenciacion del crecimiento.
WO2014065889A3 (en) Multiplexed method for diagnosing classical hodgkin lymphoma
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
ATE433124T1 (de) System und verfahren zum analysieren von radarinformationen
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
WO2011142781A3 (en) Pore-limit electrophoresis (ple) microchannel assays
MY145455A (en) Diagnostic biomolecule(s)
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
WO2013090386A3 (en) Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2009092982A3 (fr) Procédé de détection et/ou d'identification de clostridium difficile
WO2011002146A3 (ko) 악성코드 탐지시스템 및 방법
WO2011113813A3 (en) Assay for analytes based on aggregation
NZ605561A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2006099537A3 (en) The use of antibody-surrogate antigen systems for detection of analytes
IL182383A0 (en) Double hybrid system based on gene silencing by transcriptional interference
ATE449380T1 (de) System und verfahren zur quantitativen anwendungsmessung
SE0602683L (sv) Diagnostisk metod